| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |